Redemplo (plozasiran) is a type of medicine called a small interfering RNA (siRNA) therapy approved to help lower extremely high triglyceride levels in adults with familial chylomicronemia syndrome (FCS) or ongoing chylomicronemia.This medicine works by… Read more
Tzield (teplizumab-mzwv) is a prescription immune therapy that can help delay the progression of type 1 diabetes (T1D). The FDA has approved Tzield for slowing the decline of natural insulin production in children aged 8-17… Read more
Truqap (capivasertib) is an oral targeted cancer medicine. The FDA has now approved it to be used together with abiraterone and prednisone for a specific type of advanced prostate cancer. It applies to adults whose… Read more
The FDA has approved Bixlenvo for adults with HIV-1. It is meant for adults whose virus is already under control with their current HIV treatment. This means their blood test shows low levels of the… Read more
The FDA has approved Lisraya (brepocitinib) to treat adults with dermatomyositis, a rare autoimmune disease.It causes the body’s immune system to attack its own muscles and skin. People with this condition often suffer from painful… Read more
The FDA has approved Rasonque (daraxonrasib) to treat adults with advanced pancreatic cancer. The drug is for people with pancreatic adenocarcinoma that has spread to other parts of the body. It is used when patients… Read more
The FDA has approved Imaavy (nipocalimab-aahu) to treat adults and children 12 and older who have warm autoimmune hemolytic anemia (wAIHA). It is for people who are taking or have taken steroid medicines for their… Read more
The FDA has approved Ziihera (zanidatamab-hrii) to treat adults with advanced or spreading gastroesophageal adenocarcinoma (GEA). GEA includes cancers of the stomach, the esophagus, and the area where the stomach and esophagus meet. This drug… Read more
The FDA has approved Orzeyful (oveporexton) for adults with a long-term sleep disorder called narcolepsy type 1. People with this condition have extreme sleepiness during the day and a hard time focusing or staying awake.… Read more
Genglycos (pariglasgene brecaparvovec) is FDA approved for adults and children 8 and older who have glycogen storage disease type 1a (GSD1a). GSD1a is a rare genetic disorder caused by a missing enzyme called glucose-6-phosphatase (G6Pase).… Read more